As unregulated peptides grow in popularity, doctors warn of unknown risks ABC30 Fresno The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks Canada.ca Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury FDA moves toward easing restrictions on certain peptides BioPharma Dive